PlainRecalls
FDA Drug Moderate Class II Terminated

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.

Reported: January 20, 2016 Initiated: November 12, 2015 #D-0566-2016

Product Description

DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.

Reason for Recall

Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
9,717 bottles
Distribution
Nationwide
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.. Recalled by Teva Pharmaceuticals USA. Units affected: 9,717 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 20, 2016. Severity: Moderate. Recall number: D-0566-2016.